Dapagliflozin improves endothelial integrity and hemodynamics in endotoxin treated mice through an apolipoprotein M dependent pathway
Authors:
Preprint
Abstract
Rationale Sodium-glucose co-transporter inhibitors (SGLT2i) are under active clinical investigation in patients with acute inflammatory conditions, based on their clinical cardio-and nephroprotective effects, and a pre-clinical study that demonstrated SGLT2i improve renal outcomes and survival in a lipopolysaccharide (LPS) model. However, a unified mechanism that explains how SGLT2i could prevent hemodynamic consequences of inflammatory conditions has not been described. Apolipoprotein M (ApoM) is inversely associated with mortality in inflammatory conditions and improves cardiac function in endotoxin-treated mice via sphingosine-1-phosphate (S1P) signaling. Objective Test the hypothesis that pre-treatment with SGLT2i dapagliflozin (Dapa) improves hemodynamics in endotoxin-treated mice via the ApoM/S1P pathway. Methods and Results Mice with diet-induced obesity were gavaged with vehicle or Dapa for 4 days prior to LPS (10 mg/kg, IP). We found that mice receiving Dapa restored circulating ApoM levels, likely by increasing expression of the multi-ligand protein receptor megalin in the proximal tubules. Dapa attenuated LPS-induced reductions in cardiac dysfunction including reductions in ejection fraction, cardiac index, and coronary sinus area as well as vascular permeability as ascertained by intravital microscopy. Using both ApoM transgenic and knockout mice and S1P receptor inhibitors, we show that the ApoM/S1P pathway is important for the beneficial effects of Dapa in the LPS model. Conclusions In the setting of acute inflammation, our data suggest that SGLT2i maintains levels of megalin, leading to preservation of ApoM, which in turn promotes endothelial barrier integrity and improves hemodynamics. Our studies suggest a novel mechanism by which SGLT2i can preserve intravascular volume in the acute inflammatory setting.Keywords
This publication has 46 references indexed in Scilit:
- Acute endotoxemia in mice induces downregulation of megalin and cubilin in the kidneyKidney International, 2012
- Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromesCritical Care, 2012
- Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein MProceedings of the National Academy of Sciences, 2011
- Megalin is downregulated via LPS-TNF-α-ERK1/2 signaling pathway in proximal tubule cellsBiochemical and Biophysical Research Communications, 2011
- The Signal Peptide Anchors Apolipoprotein M in Plasma Lipoproteins and Prevents Rapid Clearance of Apolipoprotein M from PlasmaJournal of Biological Chemistry, 2008
- Infection and inflammation decrease apolipoprotein M expressionAtherosclerosis, 2008
- Isolation and characterization of human apolipoprotein M-containing lipoproteinsJournal of Lipid Research, 2006
- Apolipoprotein M: Progress in understanding its regulation and metabolic functionsScandinavian Journal of Clinical and Laboratory Investigation, 2006
- A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J miceDiabetologia, 2005
- Differential effects of fat and sucrose on body composition in AJ and C57BL/6 miceMetabolism, 1998